5-hydroxymethylcytosine has been researched along with Bladder Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, T; Tang, C; Wang, H; Yin, J | 1 |
| Ci, W; Ge, G; Gong, Y; Guan, B; Hao, H; He, S; He, Z; Li, X; Li, Y; Peng, D; Shi, Y; Xiong, G; Xu, Z; Zhan, Y; Zhang, C; Zhou, L; Zhou, Y | 1 |
| Li, J; Li, Q; Xu, Y; Zhang, F; Zhang, M; Zhang, Z | 1 |
3 other study(ies) available for 5-hydroxymethylcytosine and Bladder Cancer
| Article | Year |
|---|---|
Magnetic multi-enzyme cascade combined with liquid chromatography tandem mass spectrometry for fast DNA digestion and quantitative analysis of 5-hydroxymethylcytosine in genome of human bladder cancer T24 cells induced by tetrachlorobenzoquinone.
Topics: 5-Methylcytosine; Benzoquinones; Chromatography, High Pressure Liquid; DNA; Humans; Hydrocarbons, Chlorinated; Magnetic Phenomena; Nucleosides; Tandem Mass Spectrometry; Urinary Bladder Neoplasms | 2022 |
Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
Topics: 5-Methylcytosine; Aged; Animals; Ascorbic Acid; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Male; Mice; Middle Aged; Prognosis; Sequence Analysis, DNA; Sequence Analysis, RNA; Survival Analysis; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2018 |
[Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cytosine; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prognosis; Urinary Bladder Neoplasms | 2016 |